Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.

Trabert B, Coburn SB, Falk RT, Manson JE, Brinton LA, Gass ML, Kuller LH, Rohan TE, Pfeiffer RM, Qi L, Stefanick ML, Wentzensen N, Anderson GL, Xu X.

Cancer Causes Control. 2019 Nov;30(11):1201-1211. doi: 10.1007/s10552-019-01233-8. Epub 2019 Sep 21.

PMID:
31542834
2.

Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.

Hada M, Oh H, Pfeiffer RM, Falk RT, Fan S, Mullooly M, Pollak M, Geller B, Vacek PM, Weaver D, Shepherd J, Wang J, Fan B, Mahmoudzadeh AP, Malkov S, Herschorn S, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2019 Jul 23;21(1):81. doi: 10.1186/s13058-019-1162-8.

3.

Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women.

Jones GS, Spencer Feigelson H, Falk RT, Hua X, Ravel J, Yu G, Flores R, Gail MH, Shi J, Xu X, Goedert JJ.

PLoS One. 2019 May 8;14(5):e0216114. doi: 10.1371/journal.pone.0216114. eCollection 2019.

4.

Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.

Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Zeleniuch-Jacquotte A, Liu M.

Breast Cancer Res. 2019 Mar 19;21(1):42. doi: 10.1186/s13058-019-1126-z.

5.

Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.

Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X.

Int J Cancer. 2019 Oct 15;145(8):2051-2060. doi: 10.1002/ijc.32157. Epub 2019 Feb 15.

PMID:
30684389
6.

Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.

Coburn SB, Stanczyk FZ, Falk RT, McGlynn KA, Brinton LA, Sampson J, Bradwin G, Xu X, Trabert B.

Cancer Causes Control. 2019 Jan;30(1):75-86. doi: 10.1007/s10552-018-1105-1. Epub 2018 Dec 1.

PMID:
30506492
7.

Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?

Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B.

Int J Cancer. 2019 Feb 15;144(4):730-740. doi: 10.1002/ijc.31851. Epub 2018 Nov 1.

8.

Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology.

Murphy J, Pfeiffer RM, Lynn BCD, Caballero AI, Browne EP, Punska EC, Yang HP, Falk RT, Anderton DL, Gierach GL, Arcaro KF, Sherman ME.

Breast Cancer Res Treat. 2018 Nov;172(1):209-219. doi: 10.1007/s10549-018-4907-7. Epub 2018 Aug 6.

9.

Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Petrick JL, Hyland PL, Caron P, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Gapstur SM, Bradwin G, Guillemette C, Campbell PT, Cook MB.

J Natl Cancer Inst. 2019 Jan 1;111(1):34-41. doi: 10.1093/jnci/djy082.

10.

Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

Oh H, Pfeiffer RM, Falk RT, Horne HN, Xiang J, Pollak M, Brinton LA, Storniolo AMV, Sherman ME, Gierach GL, Figueroa JD.

Int J Cancer. 2018 Aug 1;143(3):496-507. doi: 10.1002/ijc.31333. Epub 2018 Apr 1.

11.

Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.

Petrick JL, Falk RT, Hyland PL, Caron P, Pfeiffer RM, Wood SN, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA, Cook MB.

PLoS One. 2018 Jan 17;13(1):e0190325. doi: 10.1371/journal.pone.0190325. eCollection 2018.

12.

Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A.

Int J Cancer. 2018 Jun 1;142(11):2215-2226. doi: 10.1002/ijc.31249. Epub 2018 Feb 8.

13.

Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study.

Playdon MC, Coburn SB, Moore SC, Brinton LA, Wentzensen N, Anderson G, Wallace R, Falk RT, Pfeiffer R, Xu X, Trabert B.

Br J Cancer. 2018 Feb 6;118(3):448-457. doi: 10.1038/bjc.2017.419. Epub 2017 Dec 12.

14.

Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.

Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB.

Prostate. 2017 Dec;77(16):1573-1582. doi: 10.1002/pros.23433. Epub 2017 Oct 2.

15.

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF.

Int J Cancer. 2018 Jan 15;142(2):262-270. doi: 10.1002/ijc.31058. Epub 2017 Oct 4.

16.

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.

Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF.

Br J Cancer. 2017 Oct 24;117(9):1412-1418. doi: 10.1038/bjc.2017.299. Epub 2017 Sep 5.

17.

Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.

Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1660-1666. doi: 10.1158/1055-9965.EPI-17-0215. Epub 2017 Aug 22.

18.

Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.

Oh H, Arem H, Matthews CE, Wentzensen N, Reding KW, Brinton LA, Anderson GL, Coburn SB, Cauley JA, Chen C, Goodman D, Pfeiffer RM, Falk RT, Xu X, Trabert B.

Br J Cancer. 2017 Sep 26;117(7):1070-1078. doi: 10.1038/bjc.2017.268. Epub 2017 Aug 17.

19.

Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.

Oh H, Coburn SB, Matthews CE, Falk RT, LeBlanc ES, Wactawski-Wende J, Sampson J, Pfeiffer RM, Brinton LA, Wentzensen N, Anderson GL, Manson JE, Chen C, Zaslavsky O, Xu X, Trabert B.

Breast Cancer Res. 2017 Mar 11;19(1):28. doi: 10.1186/s13058-017-0810-0.

20.

Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study.

Cook MB, Wood S, Hyland PL, Caron P, Drahos J, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA.

Andrology. 2017 Mar;5(2):240-247. doi: 10.1111/andr.12314. Epub 2017 Feb 27.

21.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.

Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2017 Jan 19;19(1):8. doi: 10.1186/s13058-016-0791-4.

22.

Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.

Gaudet MM, Carter BD, Brinton LA, Falk RT, Gram IT, Luo J, Milne RL, Nyante SJ, Weiderpass E, Beane Freeman LE, Sandler DP, Robien K, Anderson KE, Giles GG, Chen WY, Feskanich D, Braaten T, Isaacs C, Butler LM, Koh WP, Wolk A, Adami HO, White E, Margolis KL, Thun MJ, Gapstur SM.

Int J Epidemiol. 2017 Jun 1;46(3):881-893. doi: 10.1093/ije/dyw288.

23.

Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.

Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, Bauer DC, Dorgan JF, Shu XO, Zheng W, Brinton LA, Gail MH, Ziegler RG, Xu X, Hoover RN, Gierach GL.

Cancer Res. 2017 Feb 15;77(4):918-925. doi: 10.1158/0008-5472.CAN-16-1717. Epub 2016 Dec 23.

24.

Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women.

Murphy N, Falk RT, Messinger DB, Pollak M, Xue X, Lin J, Sgueglia R, Strickler HD, Gaudet MM, Gunter MJ.

PLoS One. 2016 Dec 8;11(12):e0167832. doi: 10.1371/journal.pone.0167832. eCollection 2016.

25.

Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Oh H, Khodr ZG, Sherman ME, Palakal M, Pfeiffer RM, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Falk RT, Horne HN, Papathomas D, Patel DA, Xiang J, Xu X, Veenstra T, Hewitt SM, Shepherd JA, Brinton LA, Figueroa JD, Gierach GL.

Horm Cancer. 2016 Dec;7(5-6):305-315. Epub 2016 May 2.

26.

A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Falk RT, Staff AC, Bradwin G, Karumanchi SA, Troisi R.

Cancer Causes Control. 2016 Aug;27(8):1009-17. doi: 10.1007/s10552-016-0779-5. Epub 2016 Jun 29.

27.

Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.

Brinton LA, Trabert B, Anderson GL, Falk RT, Felix AS, Fuhrman BJ, Gass ML, Kuller LH, Pfeiffer RM, Rohan TE, Strickler HD, Xu X, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1081-9. doi: 10.1158/1055-9965.EPI-16-0225. Epub 2016 Apr 12.

28.

Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study.

Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ, Xu X, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):648-56. doi: 10.1158/1055-9965.EPI-15-1272-T. Epub 2016 Feb 5.

29.

Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL.

Breast Cancer Res. 2016 Feb 18;18(1):24. doi: 10.1186/s13058-016-0678-4.

30.

Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.

Dallal CM, Lacey JV Jr, Pfeiffer RM, Bauer DC, Falk RT, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Veenstra TD, Xu X, Brinton LA; B∼FIT Research Group.

Horm Cancer. 2016 Feb;7(1):49-64. doi: 10.1007/s12672-015-0237-y. Epub 2016 Jan 4.

PMID:
26728471
31.

Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism.

Dallal CM, Brinton LA, Matthews CE, Pfeiffer RM, Hartman TJ, Lissowska J, Falk RT, Garcia-Closas M, Xu X, Veenstra TD, Gierach GL.

Med Sci Sports Exerc. 2016 Mar;48(3):439-48. doi: 10.1249/MSS.0000000000000790.

32.

Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry.

Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):56-62. doi: 10.1016/j.jsbmb.2015.09.032. Epub 2015 Sep 28.

33.

Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry.

Trabert B, Falk RT, Stanczyk FZ, McGlynn KA, Brinton LA, Xu X.

Horm Mol Biol Clin Investig. 2015 Sep;23(3):79-84. doi: 10.1515/hmbci-2015-0026.

34.

Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women.

Falk RT, Dallal CM, Lacey JV Jr, Bauer DC, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Pfeiffer RM, Xu X, Veenstra TD, Brinton LA; B∼FIT Research Group.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1419-22. doi: 10.1158/1055-9965.EPI-15-0541. Epub 2015 Jun 23.

35.

Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, Feigelson HS.

J Natl Cancer Inst. 2015 Jun 1;107(8). pii: djv147. doi: 10.1093/jnci/djv147. Print 2015 Aug.

36.

Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.

Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB.

J Clin Oncol. 2015 Jun 20;33(18):2041-50. doi: 10.1200/JCO.2014.59.1602. Epub 2015 May 11.

37.

Immune status of patients with inherited bone marrow failure syndromes.

Giri N, Alter BP, Penrose K, Falk RT, Pan Y, Savage SA, Williams M, Kemp TJ, Pinto LA.

Am J Hematol. 2015 Aug;90(8):702-8. doi: 10.1002/ajh.24046. Epub 2015 May 28.

38.

Relationship of serum estrogens and metabolites with area and volume mammographic densities.

Gierach GL, Patel DA, Falk RT, Pfeiffer RM, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Wang J, Fan B, Herschorn SD, Xu X, Veenstra T, Fuhrman B, Sherman ME, Brinton LA.

Horm Cancer. 2015 Jun;6(2-3):107-19. doi: 10.1007/s12672-015-0216-3. Epub 2015 Mar 11.

39.

Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium.

Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):520-31. doi: 10.1158/1055-9965.EPI-14-1009. Epub 2014 Dec 16.

40.

Circulating sex hormones and terminal duct lobular unit involution of the normal breast.

Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, Patel DA, Linville LM, Papathomas D, Clare SE, Visscher DW, Mies C, Hewitt SM, Storniolo AM, Rosebrock A, Caban JJ, Figueroa JD.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2765-73. doi: 10.1158/1055-9965.EPI-14-0667.

41.

Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry.

Fuhrman BJ, Xu X, Falk RT, Dallal CM, Veenstra TD, Keefer LK, Graubard BI, Brinton LA, Ziegler RG, Gierach GL.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2649-57. doi: 10.1158/1055-9965.EPI-14-0438.

42.

Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland.

Trabert B, Falk RT, Figueroa JD, Graubard BI, Garcia-Closas M, Lissowska J, Peplonska B, Fox SD, Brinton LA.

Cancer Causes Control. 2014 Dec;25(12):1587-93. doi: 10.1007/s10552-014-0461-8. Epub 2014 Sep 5.

43.

Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.

Black A, Pinsky PF, Grubb RL 3rd, Falk RT, Hsing AW, Chu L, Meyer T, Veenstra TD, Xu X, Yu K, Ziegler RG, Brinton LA, Hoover RN, Cook MB.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2374-82. doi: 10.1158/1055-9965.EPI-14-0700. Epub 2014 Sep 1.

44.

Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis.

Cook MB, Wood SN, Cash BD, Young P, Acosta RD, Falk RT, Pfeiffer RM, Hu N, Su H, Wang L, Wang C, Gherman B, Giffen C, Dykes C, Turcotte V, Caron P, Guillemette C, Dawsey SM, Abnet CC, Hyland PL, Taylor PR.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):673-82. doi: 10.1016/j.cgh.2014.08.027. Epub 2014 Aug 24.

45.

Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics.

Falk RT, Maas P, Schairer C, Chatterjee N, Mabie JE, Cunningham C, Buys SS, Isaacs C, Ziegler RG.

Am J Epidemiol. 2014 Oct 1;180(7):705-17. doi: 10.1093/aje/kwu189. Epub 2014 Aug 22.

46.

Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results.

Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, Sesso HD, Snyder K, Swerdlow AJ; European Rare Cancer Study Group, Trichopoulos D, Ursin G, van den Brandt PA, Van Den Eeden SK, Weiderpass E, Willett WC, Ewertz M, Thomas DB.

J Natl Cancer Inst. 2014 Mar;106(3):djt465. doi: 10.1093/jnci/djt465. Epub 2014 Feb 19. Erratum in: J Natl Cancer Inst. 2014 May;106(5):dju117.

47.

Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.

Loud JT, Gierach GL, Veenstra TD, Falk RT, Nichols K, Guttmann A, Xu X, Greene MH, Gail MH.

Breast Cancer Res Treat. 2014 Feb;143(3):517-29. doi: 10.1007/s10549-013-2821-6. Epub 2014 Jan 18.

48.

Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.

Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV Jr, Cauley JA, Hue TF, Lacroix A, Falk RT, Pfeiffer RM, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA; B~FIT Research Group.

Carcinogenesis. 2014 Feb;35(2):346-55. doi: 10.1093/carcin/bgt367. Epub 2013 Nov 8.

49.

Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.

Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, Gierach GL.

Breast Cancer Res. 2013 Apr 22;15(2):R34. doi: 10.1186/bcr3416.

50.

Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.

Yang XR, Figueroa JD, Hewitt SM, Falk RT, Pfeiffer RM, Lissowska J, Peplonska B, Brinton LA, Garcia-Closas M, Sherman ME.

Breast Cancer Res Treat. 2013 Feb;137(3):837-47. doi: 10.1007/s10549-012-2380-2. Epub 2012 Dec 28.

Supplemental Content

Support Center